Biodexa Pharmaceuticals (BDRX)

• Market cap: $4.81M
• 1 day: -6.83%
• 5 days: -10.48%
• 1 month: 14.26%
• 3 months: -8.8%
• 6 months: -45.66%
• Year to date: -81%
• 1 year: -86.76%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Employees: 13